Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003746
Filing Date
2024-02-14
Accepted
2024-02-14 16:31:04
Documents
2
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 form4-02142024_090227.html 4  
1 form4-02142024_090227.xml 4 4444
2 ex24-02142024_090227.htm EX-24 6671
  Complete submission text file 0001415889-24-003746.txt   12668
Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address
Fischer Laurent (Reporting) CIK: 0001379344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 24639113

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)